NGNE
NGNE
US64135M1053
Neurogene Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 75/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±93.3% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.1x as much as the broader market.

Beta (Market Relation)
2.09x
Above average
Volatility (5Y p.a.)
93.3% p.a.
5-Year Horizon
Max Drawdown (5Y)
-95.3%
5-Year Horizon
Sharpe Ratio
-0.32
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +2.6%
3 Years 100.8% -89.7% 0.15 +18.1%
5 Years 93.3% -95.3% -0.32 -27.6%
10 Years 87.7% -98.1% -0.26 -20.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 2.09 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (100.8%) is noticeably higher than the 5Y average (93.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (93.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -98.1% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
8 ISS Score: 8 / 10
Audit Risk
9 ISS Score: 9 / 10
Board Risk
7 ISS Score: 7 / 10
Short Ratio
15.20
ende